All things considered, it’s at least as likely to make health outcomes worse as it is to make most people healthier.

Childhood obesity continues to be a growing problem in out country. So, should the government regulate food advertising like it did with cigarettes?

A front-of-package food label would be a great educational tool. The Trump administration should keep it.

Research shows that people who take these weight-loss medications may have a lower risk of dementia and numerous other health ...

The author of a new guidebook on GLP-1s and other experts share their tips for how clinicians can optimize patient success ...

Ozempic and Wegovy, the blockbuster but costly GLP-1 drugs often used for weight loss, are among the 15 medications that will ...

T he newest weight-loss drugs, Wegovy and Zepbound, are incredibly popular. But doctors are still learning about all of the ...

Robert F. Kennedy Jr.'s anti-vaccine advocacy is outside the mainstream. His previous statements on abortion could alienate ...

Investors seeking the next obesity-like market opportunity will be closely watching developments related to treatments for ...

Novo sells semaglutide as Ozempic and Rybelsus for diabetes and as Wegovy for obesity. In price talks, CMS will treat the different forms as a single product.

The U.S. Food and Drug Administration (FDA) has approved Novo Nordisks (NYSE:NVO) Ozempic for reducing the risk of kidney ...